ADMA Biologics Inc (ADMA)
17.40
-0.50
(-2.79%)
USD |
NASDAQ |
Dec 20, 16:00
17.47
+0.07
(+0.40%)
After-Hours: 20:00
ADMA Biologics Market Cap: 4.113B for Dec. 20, 2024
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Corcept Therapeutics Inc | 5.389B |
| Alnylam Pharmaceuticals Inc | 31.66B |
| Catalyst Pharmaceuticals Inc | 2.537B |
| Sarepta Therapeutics Inc | 11.36B |
| Krystal Biotech Inc | 4.738B |
Market Cap Related Metrics
| PE Ratio | 62.14 |
| PS Ratio | 10.79 |
| Price to Book Value | 17.74 |
| Price to Free Cash Flow | 52.39 |
| Price | 17.40 |
| Earnings Yield | 1.61% |
| Operating PE Ratio | 35.94 |
| Normalized PE Ratio | 62.14 |